It is a chemicals private limited company based in Nanded, Maharashtra, India, established in 2022.
2022 | Nanded, Maharashtra, India | ActivePrimeval Pharma Private Limited, a active private limited company, was established on 08 March 2022 in Nanded, Maharashtra, India. Engaging in fine chemicals and other chemical products within the chemicals sector, it holds CIN: U24299MH2022PTC378118. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
Its leadership includes Shrikant Madhavrao Kshirsagar (Director), Rangnath Dnyaneshwar Gaikwad (Additional Director). Past directors included Shrikant Madhavrao Kshirsagar, Ravi Ramesh Shinde, Shivshankar Kondabarao Vyavhare. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.16, New Mondha Market, Nanded Waghala (M Corp),, Nanded, Maharashtra, 431603.
U24299MH2022PTC378118
378118
08 March 2022
₹1.00 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Primeval Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shrikant Madhavrao Kshirsagar | Director | 19 Apr 2024 | Current |
| Rangnath Dnyaneshwar Gaikwad | Additional Director | 12 Nov 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Director | 26 Feb 2024 | Past |
| Pramod Abcsdd | Director | 12 Nov 2024 | Past |
| Pramod Abcsdd | Director | 19 Apr 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Primeval Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Primeval Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Primeval Pharma has a workforce of 0 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Primeval Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Primeval Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Rangnath Dnyaneshwar Gaikwad was appointed as a Additional Director was appointed as a Additional Director on 12 Nov 2024 & has been associated with this company since 1 year 1 month . was documented.
The activity Primeval Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Shrikant Madhavrao Kshirsagar was appointed as a Director was appointed as a Director on 19 Apr 2024 & has been associated with this company since 1 year 7 months . was completed.
Progress on Primeval Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
The activity Primeval Pharma Private Limited was registered on 08 Mar 2022 with Roc Mumbai & aged 3 years 9 months as per MCA records. was completed.
The CIN of Primeval Pharma Private Limited is U24299MH2022PTC378118.
Primeval Pharma Private Limited is headquartered at Plot No.16, New Mondha Market, Nanded Waghala (M Corp),, Nanded, Maharashtra, 431603.
Primeval Pharma Private Limited was incorporated on 08 March 2022.
The current directors of Primeval Pharma Private Limited are
The primary industry of Primeval Pharma Private Limited is Chemicals.
Primeval Pharma Private Limited is unlisted.
The authorized capital of Primeval Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX